Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-16-004345
Filing Date
2016-09-12
Accepted
2016-09-12 09:31:40
Documents
3
Period of Report
2016-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 10651
2 NEWS RELEASE DATED SEPTEMBER 12, 2016 ex991.htm EX-99.1 8791
3 GRAPHIC image_001.jpg GRAPHIC 16626
  Complete submission text file 0001279569-16-004345.txt   43491
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 161880230
SIC: 2834 Pharmaceutical Preparations